Very Strong Quarter for Novo Despite Tresiba Setback in USA

By: Pharma News | Views: 2167 | Date: 02-May-2013

Novo Nordisk has posted yet another stellar set of figures, helped by strong sales of its diabetes drug Victoza.First-quarter net profit climbed 28% to 5.98 billion Danish kroner (about $1.06 billion), while sales were up 13% to 19.98 billion kroner. The firm's stable of modern insulin products, including Levemir (insulin detemir) and NovoRapid (insulin aspart) contributed 8.99 billion kroner, an increase of 14%.


Very Strong Quarter for Novo Despite Tresiba Setback in USA

 

Novo Nordisk

Novo Nordisk has posted yet another stellar set of figures, helped by strong sales of its diabetes drug Victoza.

First-quarter net profit climbed 28% to 5.98 billion Danish kroner (about $1.06 billion), while sales were up 13% to 19.98 billion kroner. The firm's stable of modern insulin products, including Levemir (insulin detemir) and NovoRapid (insulin aspart) contributed 8.99 billion kroner, an increase of 14%.

 

Human insulins were up 4% to 2.82 billion kroner, while oral antidiabetic products, notably NovoNorm/Prandin (repaglinide), fell 3% to 694 million kroner. As for Victoza (liraglutide), sales of Novo’s once-daily human glucagon-like peptide-1 (GLP-1) analogue reached 2.68 billion kroner, up 35%. The Danish company said Victoza now has a 68% value market share in the GLP-1 segment, compared to 61% in 2012.

 

Among the major products in Novo's biopharmaceuticals business, sales of which climbed 9% to 4.19 billion kroner, NovoSeven (recombinant Factor VIIa) was up 6% to 2.03 billion kroner, while the growth hormone Norditropin increased 14% to 1.54 billion kroner.

 

Tresiba (insulin degludec), Novo's new-generation, long-acting insulin, has been launched in the UK, Denmark and Japan and chief executive Lars Rebien Sorensen said the firm is "encouraged by the early feedback from patients and doctors". However, things are less straightforward across the pond given that Novo received a complete response letter from the US Food and Drug Administration for Tresiba and Ryzodeg (insulin degludec/insulin aspart) in February.

 

In the letter, the agency told Novo it needs to conducts a dedicated cardiovascular outcomes trial before reviews of the drugs can be completed. Mr Sorensen said "we are in a constructive dialogue with the FDA on how to resolve the issues raised" in the CRLs.

 

Novo says it now expects sales growth in 2012 of 9%-11% in local currencies, up from a previous estimate of 8%-11%, while operating profit should still increase by 10%, which reflects the expansion of sales force and marketing investments for modern insulins, Victoza in the USA and the launch of Tresiba, as well as increased investment in China.

Links

www.novonordisk.com

 

Previous Page Next Page

People Searching On This Page:
  • victoza tablet available in where in kolkata
  • tresiba in india
  • tresiba launch in india
  • tresiba manufacturer india
  • is tresiba available in kolkatA
  • When will Tresiba insulin launched in india?
  • insulin tresiba in india
  • tresiba insulin india launch
  • tresiba india

Related Pages


M.R. / Marketing Executive - Pharmaceutical Company - Lusaka

M.R. / Marketing Executive - Pharmaceutical Company - Lusaka

Jobs | Medical Representative
Date:
03-Aug-2011  Views: 5120

Job detail for the post of M.R. / Marketing Executive - Pharmaceutical Company - Lusaka - Zambia in Prime Placements and Manpower Services Lusaka , Z ...
QA Executive / Officer - Pharmaceutical Company - Lusaka - Zambia

QA Executive / Officer - Pharmaceutical Company - Lusaka - Zambia

Jobs | Quality Assurance | Ahmedabad
Date:
28-Jun-2011  Views: 5946

We are Leading Placement Consultant in Ahmedabad. We require QA Executive / QA Officer for Our Client a Leading Ltd Pharmaceutical Company Located at ...
Applications of Floating Drug Delivery Systems

Applications of Floating Drug Delivery Systems

Articles | Pharmaceutics | Tablet
Date:
08-May-2011  Views: 13077

Floating drug delivery offers several applications for drugs having poor bioavailability because of the narrow absorption window in the upper part o ...
Introduction of Parenteral Drug DeIivery System

Introduction of Parenteral Drug DeIivery System

Articles | Pharmaceutics | Parenteral
Date:
11-Apr-2011  Views: 6777

Oral drug delivery in which the systemic bio availability of a drug is often subjected to variations in gastrointestinal transit andbio transformation ...
Buccal Drug Delivery System

Buccal Drug Delivery System

Articles
Date:
18-Jun-2010  Views: 6966

Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

61  + 8 =     
Comments
People Searched About:
Victoza Tablet Available In Where In Kolkata   |   Tresiba In India   |   Tresiba Launch In India   |   Tresiba Manufacturer India   |   Is Tresiba Available In Kolkata   |   When Will Tresiba Insulin Launched In India?   |   Insulin Tresiba In India   |  
Google : 207 times | Yahoo : 12 times | Bing : 126 times |